The latest Investorplace pitch for Matt McCall’s Investment Opportunities ($99/yr) promises that we can cash in by “joining the Foldable Phone revolution”… and that sounds both fun and lucrative, so let’s check out the ad and see if the Thinkolator can ID his investment ID for you. The dream of a flexible phone screen has […]
Articles
This is a teaser pitch that we solved back in May of 2018, but folks continue to ask about it… and our older article is getting pretty stale, so we’re digging in for an updated look today. The headline of the ad pretty much says it all: “The little-known Washington D.C. financial “think tank” that […]
*** This article was originally published as part of the Friday File on March 8, 2019. It has been (very) lightly updated and unlocked for everyone to read *** Today’s teaser that we’ll feed to the Thinkolator is from Michael Robinson for his Nova-X Report ($79/year), and it sounds kind of familiar…. These Mysterious ‘M-Boxes’ […]
The ad we’re looking at today starts out with all sorts of braggadocio about how Jeff Brown at Bonner & Partners is “arrogant” or “pompous” and “egocentric” and “in your face,” and in general just not a very nice guy… the headline is “America’s Most Arrogant Investor.” That’s all malarkey — I don’t care whether […]
I haven’t written about this particular ad, but I have seen it circulating over the past couple months… and the questions keep rolling in, so I guess the ad’s still in pretty heavy rotation and it’s time to get some answers for you. The pitch is for Jeff Brown’s The Near Future Report ($99/yr “on […]
Time for some “Idea of the Month” thoughts for you, dear Irregulars. When you think the investing climate is a little more nerve-wracking than usual, why not go with a master investor who’s also nervous and is preparing for an awful economy? I’ve spoken quite a few times about my fondness for insurance company stocks. […]
I covered the first virtual reality pick hyped by Ray Blanco a few weeks ago, but I forgot to follow up and dig into the second and third picks he was teasing in that ad… so when I saw a new version of the ad circulating over the weekend, with the attention-getting “hook” changed from […]
This ad has been running again and generating a lot of questions from Gumshoe readers, so we’re re-posting the answer here. The article below has not been updated or revised since it was published on July 20, 2015, other than an update to the Irregulars “Quick Take” box and an updated disclosure at the bottom […]
Lots of questions about this one, so as I run out to a meeting today I’m re-releasing it for you — Navellier’s pitch is in heavy circulation again, and the ad is still touting the same stock as his similar ads of a month ago. The article below first ran on July 16, when the […]
Biosimilars: What Are They, and Why On Earth Should We Care?[Michael Jorrin, who we like to call “Doc Gumshoe”, is a medical writer who shares his thoughts with us once or twice a month. He does not usually recommend or discuss investments, and, as with all of our contributors, his words are his own and he chooses his own topics.] To start us off, three […]
Today we’re due for our “Idea of the Month” pick — but I also should quickly let you know that I personally added some more to my Lancashire Holdings position this week when it tripped a buy order that had been in place for a while. I wrote more about Lancashire in my insurance-themed “idea […]
This is a presentation from Mike Wood, winner of the SumZero contest for young investment analysts. He works for Samsung is not well understood, mistaken as a smartphone company — the semiconductor business is worth more than the company’s enterprise value. They have 13 products with #1 market share. People don’t believe that that this […]
As most of the Irregulars know, I try to get to all of the Value Investing Congress conferences, and I share my thoughts and notes on many of the stocks (and often invest in a few, eventually). This time I was able to make it to town in time for the pre-conference Workshop, which involves […]
We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.
More Info
Comments
No comments.